Sanofi been found to be in breach of the UK pharma industry's code of practice over a newspaper article in which it compared its respiratory syncytial virus (RSV) drug Beyfortus with a Pfizer rival.
Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once touted as a future blockbuster – after it failed the Phase 3 CMVictory trial ...